Find uplifting stories about heroes, innovations, and solutions
17777 results for "vaccine innovation"
Abu Dhabi is teaming up with global pharmaceutical company Sanofi to build a cutting-edge Vaccine Innovation Centre powered by artificial intelligence and mRNA technology. The facility will combine research, manufacturing, and pandemic preparedness under one roof to accelerate life-saving vaccine development.
Abu Dhabi's health authority is partnering with global pharmaceutical leader Sanofi to explore building a cutting-edge vaccine research center powered by AI and mRNA technology. The collaboration could accelerate how quickly new vaccines reach people who need them most.
Ethiopia's leading research institute just gained a powerful ally in the fight for better health across Africa. The World Health Organization is teaming up with the newly expanded Armauer Hansen Research Institute to develop vaccines, improve medicines, and strengthen health systems.
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
A groundbreaking vaccine protecting honeybees from a deadly disease is making history as the first approved vaccine for insects. The innovation could revolutionize how we protect both bees and other animals.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
A global vaccine alliance just secured $300 million in new partnerships to bring life-saving vaccines to remote African communities. The funding will help 140,000 children in cocoa-farming regions access immunizations in the next three years.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
A new partnership between South Korea's International Vaccine Institute and Brazil aims to mobilize $300 million to transform health innovation across the Global South. The BRIGHT Fund will help promising medical breakthroughs reach the people who need them most.
The FDA just greenlit both a new drug and a new vaccine, marking a milestone week for medical innovation. These back-to-back approvals give patients more options and show the pace of scientific progress.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
Scientists just proved that an AI-designed vaccine can trigger a human immune response, marking the first time a computer-created vaccine has worked in people. This breakthrough could revolutionize how we develop vaccines for future diseases.
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
Scientists at the University of Guelph have successfully tested the world's first vaccine against Campylobacter jejuni, a bacterial infection that causes millions of cases of severe diarrhea worldwide each year. The Phase 1 trial showed the vaccine is safe and triggers strong immune responses at even low doses.
Scientists at Stanford Medicine have developed a nasal spray vaccine that protects mice against flu, COVID, allergies, and other respiratory threats for months. If it works in humans, one spray each fall could replace multiple annual shots.
Showing 20 of 17777